PATH
Menu

A malaria vaccine, deployed in combination with current malaria-control tools, could play an important role in the future control and eventual elimination of malaria in Africa. This article, published in the New England Journal of Medicine, reports the initial results of an ongoing phase 3 trial of RTS,S/AS01 being conducted at 11 centers in seven African countries.

Corporate author(s): The RTS,S Clinical Trials Partnership

Publication date: November 2011

Available materials

English

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Africa

See also:

Vaccines and immunizationMalaria

Emerging and epidemic diseasesMalaria

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA